IN THE HIGH COURT OF NEW ZEALAND AUCKLAND REGISTRY
I TE KŌTI MATUA O AOTEAROA TĀMAKI MAKAURAU ROHE
CIV-2020-404-1915
[2020] NZHC 3343
UNDER Part 19 of the High Court Rules IN THE MATTER
of a scheme of arrangement under Part 15 of the Companies Act 1993
IN THE MATTER
of ABANO HEALTHCARE GROUP LIMITED
Applicant
Hearing: 9 December 2020 Counsel:
DJ Cooper and NW Starrenburg for applicant
JQ Wilson and JP Cooney for Adams NZ Bidco Limited
Judgment:
9 December 2020
Reasons:
16 December 2020
REASONS FOR JUDGMENT OF FITZGERALD J
This judgment was delivered by me on 16 December 2020 at 12 noon, pursuant to Rule 11.5 of the High Court Rules.
Registrar/Deputy Registrar
Date……………
Solicitors: Harmos Horton Lusk, Auckland
Bell Gully, Auckland
Re Abano Healthcare Group Limited [2020] NZHC 3343 [16 December 2020]
Introduction
[1] On 9 December 2020, I granted final orders approving a scheme of arrangement under Part 15 of the Companies Act 1993 (the Act). Those orders were in the following terms:
(a)The scheme of arrangement described in the Scheme Plan annexed to this order (the “Scheme”) is approved and binding upon:
(i)Abano Healthcare Group Limited;
(ii)Adams NZ Bidco Limited; and
(iii)Every person who is a Scheme Shareholder in terms of the Scheme Plan.
(b)Abano is granted leave to apply to the Court for approval of any amendment, modification or supplement to the Scheme.
[2]This judgment provides my reasons for making the above orders.
The parties
Abano
[3] The applicant (Abano) was incorporated in New Zealand on 1 August 1961 as New Zealand Petroleum Company Limited, and listed on the NZX in January 1970. In 1999, the company’s name was changed to Eldercare New Zealand Limited (as it focused on the development of retirement village properties and aged care services). In 2003, the company was renamed Abano, reflecting its move towards a multi- discipline approach in healthcare and medical services. In 2008, Abano entered the Australian dental market and in 2017 sold its shareholding in Ascot Radiology to focus solely on the trans-Tasman dental market.
[4] Abano operates through two brands: Lumino The Dentists (Lumino) in New Zealand and Maven Dental Group (Maven) in Australia. Its corporate office is in central Auckland.
[5]As of 31 August 2020, Abano had 228 dental practices, with:
(a)121 Lumino practices; and
(b)107 Maven practices.
[6] Abano engages over 2,030 staff or contractors across New Zealand and Australia.
[7] At the time the application for approval of the proposed Scheme of Arrangement (Scheme) was filed, Abano had 26,282,238 ordinary shares on issue (“Shares”) and as at 4 September 2020, there were 3,382 registered shareholders. All Shares are fully paid ordinary shares. At the time the application was filed, there were no shareholders that had a relevant interest in 5 per cent or more of the Shares.
[8] Abano’s Shares are widely held by institutional and retail investors either directly or through custodial services. The top 20 shareholders as at 30 September 2020 together accounted for 45 per cent of the…
Keep reading for free
Create a free CaseChat account to read Abano Healthcare Group Limited and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2020] NZHC 3343
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.